AzTrials
AzTrials

Occupational TherapyNCT06285877

Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury

A study testing Conventional therapy sessions and Conventional therapy sessions plus Nintendo Switch in people with Occupational Therapy and Acquired Brain Injury, run by Universidad Rey Juan Carlos at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. Read more about this study

Who is it for?
Ages 30 years and older
What is being tested?
Conventional therapy sessions and Conventional therapy sessions plus Nintendo Switch
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteSpain
Study dates
Feb 2024to Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult men and women, over 30 years of age who have suffered an acquired brain injury.
  • Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35).
  • Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy).
  • Agree to participate voluntarily by signing the informed consent form.

Who cannot join

  • Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35).
  • Present aphasia of comprehension or expression.
  • Present associated neurodegenerative pathology.
  • Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.).
  • Voluntarily refuse to participate in the study.

Trial locations and contacts

1 site in 1 country.

Isabel Quirosa Galan, MsC contact

+34655551210

i.quirosa.2016@alumnos.urjc.es

Spain1 site, 1 recruiting
  • Universidad Rey Juan Carlos

    Móstoles, Madrid, 28933

    Isabel Quirosa Galan, MsC, +34655551210, i.quirosa.2016@alumnos.urjc.es

    Recruiting

Other trials in Spain

About this study

Official title: Study on the Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury: A Pilot Study

Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity.

Material and methods: one group (experimental group) will receive a total of 8 one-hour sessions or 16 half-hour sessions, depending on their individual needs, for 8 weeks using the Nintendo Switch. The other group (control group) will continue to receive their conventional scheduled therapy.

Measures: Abilhand, MEC-Lobo, FIST, Fugl-Meyer, Berg Balance Scale and CSQ-8.

Being tested
Conventional therapy sessions, Conventional therapy sessions plus Nintendo Switch
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional therapy sessionsProcedure or surgery

    Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise.

  • Conventional therapy sessions plus Nintendo SwitchProcedure or surgery

    Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise plus one hour a week of Nintendo Switch.

Study groups in NCT06285877
Study groupRoleWhat they receive
Control GroupActive comparatorControl Group (CG) which received their usual sessions of conventional therapy.
Receives: Procedure: Conventional therapy sessions
Experimental GroupExperimentalExperimental Group (EG) which received therapy with Nintendo Switch plus their usual sessions of conventional therapy.
Receives: Procedure: Conventional therapy sessions plus Nintendo Switch

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Abilhand

    It is an assessment test that measures the degree of difficulty perceived by the patient in performing the 23 activities of daily living.

    Measured: Pre-intervention and post-intervention (up to 1-2 weeks)

  2. MEC-Lobo

    This is a scale that allows us to evaluate the cognitive status of patients. The lower the score, the greater the cognitive impairment.

    Measured: Pre-intervention and post-intervention (up to 1-2 weeks)

  3. Function in Sitting Test (FIST)

    It is a scale that assesses the postural control deficits presented by the patient in sedentary position in the event of imbalance, reaching on the floor, etc.

    Measured: Pre-intervention and post-intervention (up to 1-2 weeks)

  4. Fugl-Meyer

    This scale assesses the patient's motor function, sensory function, muscle balance, range of joint mobility and joint pain.

    Measured: Pre-intervention and post-intervention (up to 1-2 weeks)

  5. Berg Balance Scale (BBS)

    The scale is used to measure balance mainly in standing position in patients with different types of pathologies.

    Measured: Pre-intervention and post-intervention (up to 1-2 weeks)

Secondary outcomes (1)
  1. Client Satisfaction Questionnaire (CSQ-8)

    Self-administered questionnaire that evaluates the level of satisfaction in relation to the care and quality of care received.

    Measured: Post-intervention (up to 1-2 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Feb 2024
  2. Study startFeb 2024 (estimated)
  3. Primary completionFeb 2024 (estimated)
  4. Study completionJan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Control Group (CG), which received their usual sessions of conventional therapy sessions, and an Experimental Group (EG), which received therapy with Nintendo Switch plus their conventional therapy sessions.
Masking
None (open label)
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06285877
Sponsor's protocol ID
291120234382023
Status last verified
Feb 2024
First submitted
30 Jan 2024
Last updated
29 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional therapy sessions and Conventional therapy sessions plus Nintendo Switch in people with Occupational Therapy and Acquired Brain Injury, run by Universidad Rey Juan Carlos at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Isabel Quirosa Galan, MsC (+34655551210, i.quirosa.2016@alumnos.urjc.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Abilhand (time frame: Pre-intervention and post-intervention (up to 1-2 weeks)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in